Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

23.30
Delayed Data
As of Jul 16
 +0.01 / +0.04%
Today’s Change
10.85
Today|||52-Week Range
33.24
+22.96%
Year-to-Date
4 Warren Buffett Stocks to Buy in Q2 Earnings
Jul 13 / Zacks.com - Paid Partner Content
Has Teva Pharmaceutical Industries (TEVA) Outpaced Other Medical Stocks This Year?
Jul 11 / Zacks.com - Paid Partner Content
Mivtachim The Workers Social Insurance Fund Ltd. ...
Jul 11 / GuruFocus News - Paid Partner Content
Mivtachim The Workers Social Insurance Fund Ltd. ...
Jul 11 / GuruFocus News - Paid Partner Content
Pfizer's not the only drug company raising prices
Jul 11 / CNNMoney.com
TEVA or AKRX: Which Is the Better Value Stock Right Now?
Jul 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close23.29
Today’s open23.34
Day’s range23.10 - 23.51
Volume6,314,754
Average volume (3 months)11,000,567
Market cap$20.7B
Data as of 4:00pm ET, 07/16/2018

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)-35.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-2.90-1.75%
TYMETyme Technologies In...-0.07-2.37%
OASMOasmia Pharmaceutica...+0.12+8.84%
Data as of 4:00pm ET, 07/16/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.62
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts